Harold Van Wart

Vice Chairman at California Biomedical Innovation Alliance

Harold Van Wart

Harold Van Wart

Vice Chairman at California Biomedical Innovation Alliance

Overview
Career Highlights

CymaBay Therapeutics, Inc.

RelSci Relationships

821

Number of Boards

7

Birthday

1948

Age

72

Contact Data
Trying to get in touch with Harold Van Wart? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Harold Van Wart likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Neurelis, Inc.

Relationship likelihood: Strong

Director at Histogen, Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Amyris, Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Codexis, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Nkarta, Inc.

Relationship likelihood: Strong

Former President & Chief Executive Officer at SynGen, Inc.

Relationship likelihood: Strong

President at GeneChem Management, Inc.

Relationship likelihood: Strong

Founder at Aberdare Ventures

Relationship likelihood: Strong

Co-Founder at Rapidscan Pharma Solutions, Inc.

Relationship likelihood: Strong

General Partner at Advent Venture Partners LLP

Relationship likelihood: Strong

Paths to Harold Van Wart
Potential Connections via
Relationship Science
You
Harold Van Wart
Vice Chairman at California Biomedical Innovation Alliance
Education
Graduate Degree
Class of 1975

Cornell is a privately endowed research university and a partner of the State University of New York. As the federal land-grant institution in New York State, they have a responsibility—unique within the Ivy League—to make contributions in all fields of knowledge in a manner that prioritizes public engagement to help improve the quality of life in our state, the nation, the world.

Unknown
Class of 1969

The State University of New York at Binghamton, also known as Binghamton University is a public research university in the U.S. state of New York. The university is one of the four university centers in the State University of New York (SUNY) system. Since its establishment in 1946, the University has grown from a small liberal arts college, Harpur College, to a large doctoral-granting institution, presently consisting of six colleges and schools, and is now home to nearly 15,000 undergraduate and graduate students. The university's main campus is located in the Town of Vestal, with a secondary education center located in the nearby downtown Binghamton. Binghamton University is currently ranked 89th among the 262 national universities ranked in the 2013 U.S. News America's Best Colleges and Universities ranking and has been called a "Public Ivy".

Career History
Vice Chairman
Current

California Biomedical Innovation Alliance is an American private company located in South San Francisco, CA, with subsidiaries in the United States, that provides biomedical advocacy and community services. Sara Radcliffe is the current CEO of the firm.The company says this about itself: California Life Sciences Association (CLSA) is the state's largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California's life sciences economy. CLSA serves bio technology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged.

President, Chief Executive Officer & Director
2000 - 2017

CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce gout flares and serum uric acid. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

Vice President/Therapy Head-Arthritis & Fibrotic Diseases
1999 - 2000

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Boards & Committees
Chairman
Prior - 2014

BayBio brings together the collective strength and experience of the world’s most innovative and productive life science cluster, helping companies grow, connect and advocate to solve some of humanity’s most pressing challenges. BayBio provides comprehensive support and solutions tailored to the unique needs of nearly 1000 Bay Area life science companies and institutions, delivering tangible value through group purchasing savings, capital access, government affairs & advocacy, networking and best-practice sharing. BayBio also supports the future of bioscience innovation through the BayBio Institute’s work in science education, career development and entrepreneurship.

Transactions
Details Hidden

CymaBay Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

CymaBay Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

CymaBay Therapeutics, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Harold Van Wart. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Harold Van Wart's profile does not indicate a business or promotional relationship of any kind between RelSci and Harold Van Wart.